Condensation properties of stress granules and processing bodies are compromised in myotonic dystrophy type 1

被引:2
|
作者
Gulyurtlu, Selma [1 ]
Magon, Monika S. [1 ]
Guest, Patrick [1 ]
Papavasiliou, Panagiotis P. [1 ]
Morrison, Kim D. [1 ]
Prescott, Alan R. [2 ]
Sleeman, Judith E. [1 ]
机构
[1] Univ St Andrews, Sch Biol, Biomol Sci Res Complex, St Andrews KY16 9ST, Fife, Scotland
[2] Univ Dundee, Sch Life Sci, Div Cell Signalling & Immunol, Dundee DD1 5EH, Scotland
基金
英国惠康基金; 美国安德鲁·梅隆基金会; 英国生物技术与生命科学研究理事会;
关键词
LLPS; Myotonic dystrophy type 1; P-bodies; Stress granules; Trinucleotide repeats; MESSENGER-RNA; BINDING PROTEIN; OXIDATIVE STRESS; CAJAL BODY; TOXIC RNA; LOCALIZATION; TRANSLATION; AUTOPHAGY; CUGBP1; MODEL;
D O I
10.1242/dmm.049294
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
RNA regulation in mammalian cells requires complex physical compartmentalisation, using structures thought to be formed by liquid-liquid phase separation. Disruption of these structures is implicated in numerous degenerative diseases. Myotonic dystrophy type 1 (DM1) is a multi-systemic trinucleotide repeat disorder resulting from an expansion of nucleotides CTG (CTGexp) in the DNA encoding DM1 protein kinase (DMPK). The cellular hallmark of DM1 is the formation of nuclear foci that contain expanded DMPK RNA (CUGexp) (with thymine instead of uracil). We report here the deregulation of stress granules (SGs) and processing bodies (P-bodies), two cytoplasmic structures key for mRNA regulation, in cell culture models of DM1. Alterations to the rates of formation and dispersal of SGs suggest an altered ability of cells to respond to stress associated with DM1, while changes to the structure and dynamics of SGs and P-bodies suggest that a widespread alteration to the biophysical properties of cellular structures is a consequence of the presence of CUGexp RNA.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Distinct recruitment of human eIF4E isoforms to processing bodies and stress granules
    Frydryskova, Klara
    Masek, Tomas
    Borcin, Katerina
    Mrvova, Silvia
    Venturi, Veronica
    Pospisek, Martin
    BMC MOLECULAR BIOLOGY, 2016, 17
  • [32] Intrinsically cell-penetrating multivalent and multitargeting ligands for myotonic dystrophy type 1
    Lee, JuYeon
    Bai, Yugang
    Chembazhi, Ullas V.
    Peng, Shaohong
    Yum, Kevin
    Luu, Long M.
    Hagler, Lauren D.
    Serrano, Julio F.
    Chan, H. Y. Edwin
    Kalsotra, Auinash
    Zimmerman, Steven C.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (18) : 8709 - 8714
  • [33] CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1
    Ward, Amanda J.
    Rimer, Mendell
    Killian, James M.
    Dowling, James J.
    Cooper, Thomas A.
    HUMAN MOLECULAR GENETICS, 2010, 19 (18) : 3614 - 3622
  • [34] Life and Work of Stress Granules and Processing Bodies: New Insights into Their Formation and Function
    Perez-Pepe, Marcelo
    Fernandez-Alvarez, Ana J.
    Boccaccio, Graciela L.
    BIOCHEMISTRY, 2018, 57 (17) : 2488 - 2498
  • [35] Altered Ca2+ Homeostasis and Endoplasmic Reticulum Stress in Myotonic Dystrophy Type 1 Muscle Cells
    Botta, Annalisa
    Malena, Adriana
    Loro, Emanuele
    Del Moro, Giulia
    Suman, Matteo
    Pantic, Boris
    Szabadkai, Gyorgy
    Vergani, Lodovica
    GENES, 2013, 4 (02): : 275 - 292
  • [36] Redox imbalance in peripheral blood of type 1 myotonic dystrophy patients
    Nikolic-Kokic, Aleksandra
    Marinkovic, Dragan
    Peric, Stojan
    Stevic, Zorica
    Spasic, Mihajlo B.
    Blagojevic, Dusko
    Rakocevic-Stojanovic, Vidosava
    REDOX REPORT, 2016, 21 (05) : 232 - 237
  • [37] Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis
    Johnson, Michael E.
    Grassetti, Andrew V.
    Taroni, Jaclyn N.
    Lyons, Shawn M.
    Schweppe, Devin
    Gordon, Jessica K.
    Spiera, Robert F.
    Lafyatis, Robert
    Anderson, Paul J.
    Gerber, Scott A.
    Whitfield, Michael L.
    ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [38] Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis
    Michael E. Johnson
    Andrew V. Grassetti
    Jaclyn N. Taroni
    Shawn M. Lyons
    Devin Schweppe
    Jessica K. Gordon
    Robert F. Spiera
    Robert Lafyatis
    Paul J. Anderson
    Scott A. Gerber
    Michael L. Whitfield
    Arthritis Research & Therapy, 18
  • [39] The myotonic dystrophy type 1 drug development pipeline: 2022 edition
    Pascual-Gilabert, Marta
    Artero, Ruben
    Lopez-Castel, Arturo
    DRUG DISCOVERY TODAY, 2023, 28 (03)
  • [40] THE USE OF BUCCAL CELLS FOR RAPID DIAGNOSIS OF MYOTONIC DYSTROPHY TYPE 1
    Holt, Ian
    Quinlivan, Ros C. M.
    Couto, Jillian M.
    Monckton, Darren G.
    Morris, Glenn E.
    TRANSLATIONAL NEUROSCIENCE, 2010, 1 (03) : 195 - 199